Re: How do these drugs work? In phase III trials

Posted by linkadge on July 3, 2005, at 18:15:44

In reply to How do these drugs work? In phase III trials, posted by ravenstorm on July 3, 2005, at 17:56:33

I think the NK2 antagonist is a substance P antagonist.
These drugs seem to block the activity of substance P, which I believe, is a form of neurotransmitter that transmits signals of pain (presubably both emotional and physical pain)

Linkadge

Thread

How do these drugs work? In phase III trials ravenstorm 7/3/05
Re: How do these drugs work? In phase III trials linkadge 7/3/05
Saredutant looks like a winner Shawn. T. 7/3/05
Re: How many years until these hit the market? (nm) ravenstorm 7/4/05
Re: Saredutant looks like a winner ravenstorm 7/4/05
Re: How many years until these hit the market? Shawn. T. 7/4/05
Re: Saredutant looks like a winner Shawn. T. 7/4/05
Re: Saredutant looks like a winner, trials? ravenstorm 7/4/05
Re: Saredutant looks like a winner linkadge 7/4/05
Re: Saredutant looks like a winner linkadge 7/4/05
Re: Saredutant looks like a winner, trials? Shawn. T. 7/5/05
Re: Saredutant looks like a winner » linkadge Shawn. T. 7/5/05
Re: thanks everybody (nm) ravenstorm 7/5/05
Re: Saredutant looks like a winner linkadge 7/5/05
...
Re: Saredutant doesn't look like a winner cache-monkey 6/4/08

Post a new follow-up

Notify the administrators

Start a new thread

poster:linkadge thread:523047
URL: http://www.dr-bob.org/babble/20050702/msgs/523057.html

	for
in